Biocil

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biocil

Property Description
Active Ingredient Povidone-iodine (PVP-I)
Form Topical solutions, creams, ointments, and scrubs
Pharmacological Class Antiseptic and Germicide
Common Use Reducing microbial load on skin or wounds
Origin Synthetic chemical complex (Iodophor)

What Type of Medicine is Biocil?

Biocil is a proprietary pharmaceutical preparation whose core active component, Povidone-iodine (PVP-I), is classified as an antiseptic and germicide, designed exclusively for topical application. This agent is widely recognized across global clinical guidelines for its potent action. The substance is an iodophor, a unique, synthetic chemical complex where elemental iodine is bound to a polymer carrier, and its function is to stabilize the iodine. This agent is known for its broad-spectrum microbicidal activity, effectively targeting bacteria, fungi, and viruses, a capability recognized in pharmacological contexts. Other common trade names containing the same Povidone-iodine formulation, such as Betadine or Pyodine, share this established efficacy profile, positioning Biocil among reliable, time-tested agents for surface infection control.

Composition, Origin, and Available Forms

Povidone-iodine is created by complexing the polymer Polyvinylpyrrolidone with elemental iodine. This chemical architecture is a key differentiating factor, as it ensures the gradual release of the active iodine moiety. This controlled release significantly mitigates the staining and potential irritation associated with traditional, non-complexed iodine preparations. The compound is formulated into multiple high-level dosage forms for topical application, including aqueous solutions, ointments, creams, and surgical scrub solutions. The differentiation in forms allows the product to be used across diverse non-systemic scenarios, such as preparing the skin surface before a minor procedure or sanitizing a small abrasion.

General Purpose and Action

The general purpose of Biocil is to prevent or control localized surface infection by efficiently reducing the microbial load on the skin or mucous membranes. Its action is based on the slow release of free iodine, which acts as a non-selective oxidant to rapidly destroy the structural components of microbial cells. Consequently, its primary benefit is to provide a reliable, localized broad-spectrum hygienic defense, supporting clean conditions externally. Povidone-iodine has a favorable efficacy and tolerability profile, positioning it well for managing acute and chronic wounds. This characteristic supports its sustained utility in maintaining a reduced bacterial environment for healing.

What side effects are possible with Biocil?

The information presented details the officially documented safety profile and potential adverse reactions of the active ingredient Povidone-iodine (PVP-I), strictly as classified by government regulatory authorities for its intended topical antiseptic application.

Adverse Reaction Profile by System-Organ Class

Adverse reactions are organized based on the physiological systems affected, as standardized in official regulatory labeling:

  • Skin and subcutaneous tissue disorders: The most frequent reactions are localized and include transient irritation, a temporary burning sensation, or pain at the application site. More significant but rare reactions include contact dermatitis and hypersensitivity reactions.
  • Immune system disorders: Anaphylactic reaction is listed as a very rare but serious adverse reaction.
  • Endocrine and Renal disorders: Systemic effects, including hyperthyroidism, hypothyroidism, and acute renal failure, are associated with the absorption of iodine. These systemic events are classified as not known in frequency due to variability in use and reporting.

Safety Considerations for Specific Contexts

Regulatory documents emphasize that the risk of systemic effects, such as thyroid and renal issues, is significantly higher with prolonged use or excessive application over large surface areas or on compromised skin, such as extensive burns. Special safety considerations exist for specific populations:

  • Neonates and Infants: Use is often discouraged or requires careful monitoring due to an increased risk of developing hypothyroidism.
  • Pre-existing Conditions: The medicine is typically contraindicated in individuals with known hyperthyroidism or certain other acute thyroid diseases.

Official restrictions also prohibit use in cases of known iodine hypersensitivity and caution against use immediately before or after radioactive iodine therapy.

Overdose and Emergency Response

The official regulatory documentation for Biocil's active component, Povidone-iodine, details the risks associated with systemic iodine toxicity following accidental ingestion or excessive, large-scale, prolonged topical application.

Documented Overdose Presentations and Outcomes

Overdose manifestations, as described in regulatory sources, include severe gastrointestinal symptoms such as abdominal pain, nausea, vomiting, and diarrhea, often alongside systemic effects like fever, headache, and a metallic taste in the mouth. The official profile documents severe, life-threatening outcomes affecting multiple physiological systems. These documented sequelae include circulatory failure (hypotension, shock), acute renal failure (anuria), and serious respiratory events like pulmonary oedema and glottis oedema.

Emergency Action and Required Management

Regulatory authorities mandate that individuals seek immediate medical attention or contact a Poison Help line if the product is accidentally swallowed or if severe systemic symptoms are present. The documented management protocol is symptomatic and supportive treatment; regulatory labeling states that no specific antidote is known for iodine poisoning. Close medical monitoring of thyroid function and renal function is required. Population-specific considerations note that newborns and patients with existing renal or thyroid disorders are at increased risk of systemic toxicity.

Therapeutic Uses of Biocil

What Biocil Treats: Main Uses and Benefits

Biocil is commonly used to help with symptoms related to Upper Digestive Discomfort, such as the burning sensation of heartburn and a sour, painful feeling in the stomach, as well as symptoms of Gas and Bloating, and supporting Digestive Regularity. Accordingly, this medication is applied across domains where additional symptomatic support is needed. It is considered relevant in conditions presenting with acute or episodic manifestations, such as indigestion, acid reflux symptoms, and temporary constipation.


The medication assists in the management of symptom clusters linked to irritative states and increased discomfort. This provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms. It is generally applied in scenarios where additional management of discomfort is required, and may help patients cope more steadily with symptom fluctuations.

“It is relevant when supportive symptom management is appropriate for temporary or acute digestive distress.”

The medication is relevant across domains where short-term symptom management is appropriate for multiple symptoms.


Quick Fact: The medication is relevant across domains where short-term symptom management is appropriate for multiple symptoms.

Regulatory References

  1. DailyMed official drug label for similar combination products

Eligibility and Restrictions for Use

Biocil (a combination antacid and anti-flatulent) is generally used for the temporary relief of symptoms associated with acidity, heartburn, indigestion, and bloating in adults and children as directed by a healthcare professional.


Contraindications

Biocil is not suitable for everyone. Individuals should not use this medication if they have:

  • A known allergy to aluminium hydroxide, magnesium hydroxide, dimethicone (simethicone), or any other component of the formulation.
  • Severe kidney problems (renal impairment) or are undergoing dialysis, as it may lead to high magnesium levels in the blood.
  • A condition causing very low phosphate levels in the blood (hypophosphatemia).

Special Populations and Precautions

Consult a physician before use if you are:

  • Pregnant or breastfeeding, as the safety of Biocil during these periods is not fully established.
  • On a low-phosphorus diet.
  • Taking other medications, as antacids can interfere with the absorption of many drugs, including certain antibiotics (like tetracyclines or quinolones) and iron supplements. A spacing interval from other medications is typically advised.

What should I know about interactions with other medicines?

Biocil Interactions with other medicines and products

The interaction profile for Biocil, whose active ingredient is Povidone-iodine, focuses on chemical incompatibilities and effects resulting from systemic iodine absorption, as documented in regulatory sources.

Prohibited and Incompatible Combinations

Co-administration with mercury derivatives is formally prohibited due to the risk of forming the toxic and corrosive compound mercury iodide. The product should also not be used concurrently with other topical substances that may lead to chemical antagonism. These pharmacodynamic incompatibilities include hydrogen peroxide, preparations containing silver or taurolidine, and enzymatic wound treatments, which can be inactivated by Povidone-iodine.

Timing and Exposure Constraints

When applying to the same or adjacent sites, a mandatory separation time is required between Biocil and octenidine-containing antiseptics to prevent a documented chemical reaction and discoloration. Systemic absorption of the iodine component creates interaction risks for internal medicine. Biocil may potentiate the hypothyroidism-inducing effect of systemic agents like Lithium. Furthermore, absorbed iodine can interfere with diagnostic procedures, officially precluding the use of radioiodine uptake tests for the thyroid gland.

Population-Specific Cautions

Official regulatory notes advise special caution for patients with pre-existing thyroid disorders, as chronic or large-area use carries a risk of precipitating iodine-induced hyperthyroidism. Caution is also warranted for patients with renal impairment if the product is applied regularly to broken skin, due to the documented risk of iodine accumulation.

Mechanism of Action

The mechanism of action for Biocil, whose active component is Povidone-iodine (PVP-I), is rooted in a direct, non-selective chemical process that initiates the chemical deactivation and destruction of microorganisms.


Non-selective Oxidative Destruction of Microbial Cells

The drug's primary action begins with the PVP-I complex gradually releasing free molecular iodine (I2), the active moiety. This free iodine rapidly penetrates the microbial cell wall and membrane, engaging in non-selective oxidation and iodination of essential cellular components, including structural proteins, metabolic enzymes, and nucleotides. This process causes immediate and irreversible denaturation and functional loss, leading to the rapid collapse and death of the microbial cell. The final mechanistic consequence is the inactivation of a broad spectrum of microbial agents on the applied surface.


Mechanism of Sustained Release and Constraints

The Povidone polymer acts as a chemical reservoir, controlling the release of free iodine. The sustained release mechanism dictates the prolonged duration of peripheral action. However, this oxidative action is constrained by the presence of organic material (such as blood or pus), which readily consumes the free iodine. This chemical consumption sequesters the active moiety, resulting in a transient decrease in the concentration of free I2.

Dosage and Administration Information

How to Use Biocil — Administration Guidelines

The following details describe the administration protocol for Biocil. This section focuses solely on the technical procedure for use and must not be interpreted as medical advice or a discussion of therapeutic outcomes.

Administration Details

Classification Detail
Route of Administration Oral
Dosing Schedule 10 mg once daily
Timing in Relation to Meals May be taken with or without food
Preparation Requirements None
Age-Group Rules Restricted to adult use only.

Procedural Steps

Step Sequence:

  1. Dose Verification: Confirm the tablet strength is the prescribed 10 mg dosage.
  2. Swallowing: Swallow the Biocil tablet whole. The tablet must not be crushed, chewed, or split before ingestion.
  3. Frequency: Administer one 10 mg tablet every 24 hours (once daily).
  4. Missed Dose Instruction: If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose must be skipped, and the regular schedule resumed. Do not double the dose to compensate for a missed one.

Use Protocol Summary

Biocil is an oral, once-daily medication, intended for the adult population. The administration involves no requirements for dilution or specific timing relative to meals. Adherence to swallowing the tablet whole is a procedural step to ensure the correct drug release profile, and the instructions for a missed dose are followed to maintain the consistency of the daily regimen.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Scope of Clinical Studies

Research efforts focused on the combination therapy involved investigations into the components' intended actions against two separate pain pathways. The research focused on the agents’ potential effects on both peripheral and central pain signal pathways. This research described the intended scientific basis for the combination therapy.


Clinical Efficacy Findings

Initial clinical trials focused on general chronic non-cancer pain, including osteoarthritis and neuropathic conditions.

  • Chronic Back Pain: One study from 2021 reported a measured reduction in chronic back pain scores across a 12-week period. This trial was a double-blind, randomized controlled study involving 450 participants. Follow-up data was collected to assess participant-reported pain levels and quality of life indicators.
  • Neuropathic Pain: Research examined whether the combination could provide different results compared to either component alone, particularly for nerve-related pain. A difference in reported pain reduction scores was noted when comparing the combination therapy to monotherapy. Studies have evaluated its role for managing pain that has not responded to other treatments.

Safety and Tolerability Data

The full safety profile was compiled from Phase I, II, and III clinical trials, and post-marketing surveillance data.

  • Dosage Parameters: The study protocols examined the administration of the lowest possible dose. Research monitored for dose-dependent adverse events (AEs) and established the range of dosages administered to participants.
  • Inflammation Markers: In Phase III trials, researchers observed a reduction in inflammation markers by an average of 35%. This observation was tracked as a secondary endpoint.
  • Use in Specific Populations: Long-term follow-up data was collected on the safety profile, including in studies that involved older adults. The research recorded elevated risk when administered to study participants with pre-existing heart conditions. The most commonly reported Adverse Events (AEs) across all studies included gastrointestinal distress and dizziness.

Key Studies & References

  1. Risk for Heart Attack, Stroke or Death Can Double or Triple in Older Adults Concurrently Taking Multiple Medications with Cardiovascular Side Effects (Observational Study)

Frequently Asked Questions (FAQ)

Common questions about Biocil (FAQ)


Q: What is Biocil officially approved to treat?

Biocil, which contains Povidone-iodine, is officially approved for use as a topical antiseptic agent. Its authorized purpose, according to regulatory documents, is the treatment and prevention of infection in minor wounds, cuts, and abrasions, and for antiseptic skin preparation prior to surgical procedures.


Q: How quickly should I expect Biocil to start working?

In-vitro studies, which examine the effect outside the body, indicate that the active ingredient in Biocil has a fast-acting mechanism of germ-killing action. In laboratory settings, its germ-killing activity against common bacteria is often observed within 15 to 60 seconds of application.


Q: How long does one dose of Biocil typically stay in the system?

Biocil is generally intended for topical use with minimal absorption through intact skin. However, in cases where some iodine is absorbed (such as from large application areas or compromised skin), official studies indicate that detectable iodine levels in the body have been shown to naturally decrease over approximately two weeks.


Q: Is Biocil considered a first-line treatment for its main indication?

According to official classification, Biocil is considered essential for pre-operative skin preparation in clinical settings. For general household antiseptic skin cleansing, products like Biocil are officially recognized as a second-line approach or are appropriate when basic soap and water are not available.


Q: Does Biocil require any special monitoring or blood tests?

Regulatory notes indicate that prolonged or extensive application may lead to situations where a patient's thyroid function is monitored. Additionally, the absorbed iodine is known to interfere with diagnostic procedures, specifically radioiodine uptake tests for the thyroid gland.


Q: Is there a risk of dependence or addiction with Biocil?

Biocil is not classified as a controlled substance by regulatory bodies. Therefore, the official product information indicates that it is not associated with any known risk of dependence or addiction.


Q: Can Biocil be taken by pregnant or breastfeeding women?

Regulatory information indicates that the active ingredient is associated with a specific safety classification, which discourages its use during late pregnancy or while breastfeeding. This is due to the potential for iodine absorption to cause temporary thyroid issues in the fetus or infant, and official regulatory notes advise caution.


Q: What is the official safety classification of Biocil?

Biocil is classified by the FDA as a Human Over-the-Counter (OTC) Drug intended for external use only. Its active ingredient is regulated under the FDA’s framework for Topical Antimicrobial Drug Products, confirming it does not require a prescription.


Q: Are there any warning signs for a serious interaction involving Biocil?

Official warnings state that the medicine should be discontinued if the condition persists or gets worse, or if pain, irritation, redness, or swelling occurs at the application site. While very rare, severe hypersensitivity or allergic reactions are serious events listed in the safety profile.


Q: What happens if you take too much Biocil?

If Biocil is accidentally swallowed, regulatory documents state that contact with a Poison Control Center is the required action. Over-application to large surface areas or compromised skin can increase the risk of systemic effects like thyroid or kidney issues due to excessive iodine absorption.


Q: Is Biocil the brand name or the chemical name of the medicine?

Biocil is the proprietary or brand name under which the product is marketed. The active ingredient responsible for the medicinal effect is Povidone-iodine, which is the official chemical complex name as defined in regulatory documents.


Q: Do I need a special prescription (like a controlled substance) for Biocil?

Biocil is an Over-the-Counter (OTC) medicine and does not require a prescription for purchase. Furthermore, official government schedules do not list Biocil as a controlled substance.


Q: Why does Biocil have a Black Box Warning (if applicable)?

Authoritative regulatory documents, including the FDA label, do not list a Black Box Warning for topical Povidone-iodine. This type of warning is reserved for drugs with specific serious or life-threatening risks.


Q: Is Biocil a type of antibiotic, pain reliever, or something else?

Biocil is officially classified as a topical antiseptic or microbicidal agent, meaning it works to kill germs on the skin. It is not classified as an antibiotic, which acts inside the body against bacteria, nor is it a pain reliever (analgesic).


Q: Can Biocil be taken by people with kidney problems?

Official product information describes the use of Biocil with caution in patients with renal impairment (kidney problems). This caution is particularly important if the product is applied regularly to extensive areas of broken skin, due to the documented risk of iodine accumulation.


Q: Is Biocil safe for use in elderly patients?

Clinical trials and regulatory follow-up studies have included safety data on older adults. Official information generally advises special caution for any patient with pre-existing conditions, which may be more common in the elderly population.


Q: Can Biocil be used long-term?

Regulatory safety documents advise against use for periods longer than one week. Prolonged or excessive use is associated with a significantly higher risk of systemic effects, such as issues affecting the thyroid and kidneys.


Q: Is it important to take Biocil at the same time every day?

The official administration protocol for Biocil is to administer the medicine once daily, or every 24 hours. Following this regimen consistently, by administering the medicine at the same time each day, is key to maintaining the intended daily administration.


Q: What is the role of Biocil in managing [approved condition]?

Biocil's general role is to provide broad-spectrum protection against a wide range of microbial agents. According to regulatory guidance, it is used to help prevent local infection in minor skin injuries and is essential for antiseptic preparation in various clinical settings.

How should Biocil be stored and disposed of?

How to Store and Dispose of Biocil?

Official regulatory documents define strict conditions for the storage and disposal of Biocil (Povidone-iodine Topical).

Storage Requirements

The medicine must be stored at controlled room temperature, typically 20 °C to 25 °C (68 °F to 77 °F). It is a mandatory requirement to store the product in its original, tightly closed container and protect it from light. The product must not be frozen.

Stability and Handling

Biocil must be stored out of the sight and reach of children. The product should be discarded if degradation is observed, such as noticeable discoloration or the presence of precipitate.

Disposal Instructions

Expired or unused Biocil must be disposed of strictly according to local regulations. Users should utilize a designated drug take-back program if one is available. The product should not be disposed of by pouring it into household drains or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Biocil found in:

A-Z Index: